ESMO 2024
PULMÓN
OTROS TUMORES DEL TÓRAX
Tu canal independiente de oncología en español
Top resúmenes y presentaciones
PECATI: A phase II trial to evaluate the efficacy and safety
of lenvatinib in combination with pembrolizumab in
pretreated advanced B3-thymoma and thymic carcinoma
LBA83
ARTIMES: Automated Response evaluation to Treatment In
MESothelioma
1910MO
Updated survival and vaccine response from the NIPU trial:
A randomised, phase II study evaluating nivolumab and
ipilimumab with or without UV1 vaccination in patients with
pleural mesothelioma
1917P
Molecular analysis of mesothelioma reveals mutations as
prognostic biomarkers for patients treated with the
combination of ipilimumab and nivolumab
1921P
Nintedanib(N) as switch maintenance treatment in
malignant pleural mesothelioma (MPM) (NEMO): A
double-blind randomized phase II trial (EORTC-08112-LCG)
1914P
Durvalumab (D) as consolidation therapy in limited-stage
SCLC (LS-SCLC): Outcomes by prior concurrent
chemoradiotherapy (cCRT) regimen and prophylactic
cranial irradiation (PCI) use in the ADRIATIC trial
LBA81
LOCALMENTE AVANZADO O METASTÁSICO
Regístrate aquí para recibir más contenidos
Registrarse